Term: | Pancreatic endocrine tumor |
|
Accession: | HP:0030405
|
browse the term
|
Definition: | A neuroendocrine tumor originating in a hormone-producing cell (islet cell) of the pancreas. |
Synonyms: | exact_synonym: | Pancreatic endocrine tumour |
| xref: | SNOMEDCT_US:126864006; SNOMEDCT_US:128878003; SNOMEDCT_US:237596009; SNOMEDCT_US:399528006; SNOMEDCT_US:76345009; UMLS:C0242363 |
|
|
|
G |
CCND1 |
cyclin D1 |
|
IAGP |
|
HPO |
|
ORPHA:892 |
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
|
IAGP |
|
HPO |
|
ORPHA:652 |
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
|
|
G |
CDKN1B |
cyclin dependent kinase inhibitor 1B |
|
IAGP |
|
HPO |
|
MIM:610755 ORPHA:652 |
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
|
|
G |
CDKN2B |
cyclin dependent kinase inhibitor 2B |
|
IAGP |
|
HPO |
|
ORPHA:652 |
NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
|
|
G |
CDKN2C |
cyclin dependent kinase inhibitor 2C |
|
IAGP |
|
HPO |
|
ORPHA:652 |
NCBI chr 1:50,960,745...50,974,634
Ensembl chr 1:50,960,745...50,974,634
|
|
G |
DAXX |
death domain associated protein |
disease_progression |
IAGP |
DNA:frameshift, frameshift mutations, nonsense mutation, missense mutations:CDS:multiple |
RGD |
PMID:29212165 |
RGD:152025205 |
NCBI chr 6:33,318,558...33,322,959
Ensembl chr 6:33,318,558...33,323,016
|
|
G |
IFNG |
interferon gamma |
|
IAGP |
|
HPO |
|
ORPHA:805 |
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
MEN1 |
menin 1 |
|
IAGP |
|
HPO |
|
ORPHA:652 |
NCBI chr11:64,803,516...64,811,294
Ensembl chr11:64,803,510...64,811,294
|
|
G |
TSC1 |
TSC complex subunit 1 |
|
IAGP |
|
HPO |
|
ORPHA:805 |
NCBI chr 9:132,891,349...132,945,378
Ensembl chr 9:132,891,348...132,946,874
|
|
G |
TSC2 |
TSC complex subunit 2 |
|
IAGP |
|
HPO |
|
ORPHA:805 |
NCBI chr16:2,047,985...2,089,491
Ensembl chr16:2,047,967...2,089,491
|
|
G |
VHL |
von Hippel-Lindau tumor suppressor |
|
IAGP |
|
HPO |
|
ORPHA:892 |
NCBI chr 3:10,141,778...10,153,667
Ensembl chr 3:10,141,778...10,153,676
|
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
|
IAGP |
|
HPO |
|
ORPHA:652 |
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
|
|
G |
CDKN1B |
cyclin dependent kinase inhibitor 1B |
|
IAGP |
|
HPO |
|
ORPHA:652 |
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
|
|
G |
CDKN2B |
cyclin dependent kinase inhibitor 2B |
|
IAGP |
|
HPO |
|
ORPHA:652 |
NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
|
|
G |
CDKN2C |
cyclin dependent kinase inhibitor 2C |
|
IAGP |
|
HPO |
|
ORPHA:652 |
NCBI chr 1:50,960,745...50,974,634
Ensembl chr 1:50,960,745...50,974,634
|
|
G |
GCGR |
glucagon receptor |
|
IAGP |
|
HPO |
|
ORPHA:438274 |
NCBI chr17:81,804,150...81,814,008
Ensembl chr17:81,804,132...81,814,008
|
|
G |
MEN1 |
menin 1 |
|
IAGP |
|
HPO |
|
MIM:131100 ORPHA:652 |
NCBI chr11:64,803,516...64,811,294
Ensembl chr11:64,803,510...64,811,294
|
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
|
IAGP |
|
HPO |
|
ORPHA:652 |
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
|
|
G |
CDKN1B |
cyclin dependent kinase inhibitor 1B |
|
IAGP |
|
HPO |
|
ORPHA:276152 ORPHA:652 |
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
|
|
G |
CDKN2B |
cyclin dependent kinase inhibitor 2B |
|
IAGP |
|
HPO |
|
ORPHA:652 |
NCBI chr 9:22,002,903...22,009,313
Ensembl chr 9:22,002,903...22,009,305
|
|
G |
CDKN2C |
cyclin dependent kinase inhibitor 2C |
|
IAGP |
|
HPO |
|
ORPHA:652 |
NCBI chr 1:50,960,745...50,974,634
Ensembl chr 1:50,960,745...50,974,634
|
|
G |
MAFA |
MAF bZIP transcription factor A |
|
IAGP |
|
HPO |
|
MIM:147630 |
NCBI chr 8:143,428,064...143,430,732
Ensembl chr 8:143,419,182...143,430,732
|
|
G |
MEN1 |
menin 1 |
|
IAGP |
|
HPO |
|
MIM:131100 ORPHA:652 |
NCBI chr11:64,803,516...64,811,294
Ensembl chr11:64,803,510...64,811,294
|
|
|
G |
KCNJ11 |
potassium inwardly rectifying channel subfamily J member 11 |
|
IAGP |
|
HPO |
|
ORPHA:79644 |
NCBI chr11:17,385,248...17,389,346
Ensembl chr11:17,365,172...17,389,331
|
|
G |
MAFA |
MAF bZIP transcription factor A |
|
IAGP |
|
HPO |
|
MIM:147630 |
NCBI chr 8:143,428,064...143,430,732
Ensembl chr 8:143,419,182...143,430,732
|
|
|
G |
CCND1 |
cyclin D1 |
|
IAGP |
|
HPO |
|
ORPHA:892 |
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
MEN1 |
menin 1 |
|
IAGP |
|
HPO |
|
MIM:131100 |
NCBI chr11:64,803,516...64,811,294
Ensembl chr11:64,803,510...64,811,294
|
|
G |
VHL |
von Hippel-Lindau tumor suppressor |
|
IAGP |
|
HPO |
|
ORPHA:892 |
NCBI chr 3:10,141,778...10,153,667
Ensembl chr 3:10,141,778...10,153,676
|
|
Term paths to the root
|